Showing results (161-170 of 278) with videos related to

Sort By:
Pageof 28
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Communications Biology|October 2, 2018
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cellsMaria Blasi, Donatella Negri, Celia LaBranche, et al.
Journal of Immunological Methods|June 10, 2014
The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cellsMarcella Sarzotti-Kelsoe, Leila K Needham, Wes Rountree, et al.
The Lancet. HIV|October 3, 2020
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R Baden, Daniel J Stieh, Michal Sarnecki, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
Molecular Systems Biology|May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protectionSrivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Journal of Virology|March 4, 2016
Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast MilkCody S Nelson, Justin Pollara, Erika L Kunz, et al.
Plos Medicine|November 15, 2017
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trialKenneth H Mayer, Kelly E Seaton, Yunda Huang, et al.
Pageof 28